SCHEMBL22982038

SCHEMBL22982038

COCc1nn(Cc2ccc3c(c2)CN(C2CC2)CC3)cc1C(=O)NCc1c(-n2cc(C)nn2)ccc(OC)c1F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ F11 P03951 7/20 1.00
▸ KLKB1 P03952 15/20 0.95

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29405473 1.00 F11 (1.00) F11KLKB1
SCHEMBL29405517 0.97 KLKB1 (1.00) F11KLKB1
SCHEMBL29405458 0.95 KLKB1 (1.00) F11KLKB1
SCHEMBL22981502 0.92 F11 (0.85) F11KLKB1
SCHEMBL29407281 0.92 F11 (0.85) F11KLKB1
SCHEMBL29407297 0.90 F11 (0.90) F11KLKB1
SCHEMBL29697514 0.90 KLKB1 (0.84) F11KLKB1
SCHEMBL29388508 0.89 F11 (0.81) F11KLKB1
SCHEMBL22981556 0.89 KLKB1 (0.83) F11KLKB1
SCHEMBL29405129 0.89 KLKB1 (0.83) F11KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010333-A1 PLASMA KALLIKREIN INHIBITORS Kalvista Pharmaceuticals Limited (GB) 2022-06-15 — — EP disclosed
WO-2021028649-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 — — WO disclosed
WO-2021028645-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 — — WO disclosed
Send feedback